Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL407693 | 1.00 | ALDH1A1 (0.50) | ALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL8157111 | 0.79 | ALDH1A1 (0.41) | ALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL1990356 | 0.79 | ALDH1A1 (0.41) | ALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL3845474 | 0.79 | ALDH1A1 (0.41) | ALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL6903942 | 0.76 | ALDH1A1 (0.39) | ALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL9066678 | 0.74 | ALDH1A1 (0.54) | ALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL1479028 | 0.74 | — | — | |
| SCHEMBL65852 | 0.74 | — | — | |
| SCHEMBL3465262 | 0.73 | ALDH1A1 (0.37) | ALDH1A1HSD17B10 | |
| SCHEMBL22722069 | 0.73 | ALDH1A1 (0.37) | ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2201946-A1 | PAI-1 PRODUCTION INHIBITOR | Institute of Medicinal Molecular Design, Inc. (JP) | 2010-06-30 | — | — | EP | disclosed |
| US-20090239868-A1 | INHIBITOR OF PAI-1 PRODUCTION | INSTITUTE OF MEDICAL MOLECULAR DESIGN, INC. | 2009-09-24 | — | — | US | disclosed |
| EP-0248421-B1 | Carrier for developer | FUJI XEROX CO LTD (JP) | 1994-09-07 | — | — | EP | disclosed |
| US-5110703-A | Particles of magnetic powder in binder resin blend of polyolefin and olefin polymer having functional group | FUJI XEROX CO., LTD. (JP) | 1992-05-05 | — | — | US | disclosed |
| US-4965160-A | CHARGE QUALITY | FUJI XEROX CO., LTD. (JP) | 1990-10-23 | — | — | US | disclosed |
| US-4868083-A | Developer carrier and process for producing the same | FUJI XEROX CO., LTD. (JP) | 1989-09-19 | — | — | US | disclosed |
| US-4791041-A | FLUORINATED ALKYL (METH)ARYLATE COPOLYMER OVERCOATINGS; ANTISOILANTS; ANTISTICKING AGENTS | FUJI XEROX CO., LTD. (JP) | 1988-12-13 | — | — | US | disclosed |
| EP-0248421-A2 | Carrier for developer | FUJI XEROX CO., LTD. (JP) | 1987-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090239868-A1 | INHIBITOR OF PAI-1 PRODUCTION | SERPINE1, SERPINC1, SERPINH1 | ALDH1A1 289/4885HSD17B10 1263/4885MEN1 391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.